EBMT 2024 | The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños
• 16 Apr 2024
Natacha Bolaños, Lymphoma Coalition Europe, Madrid, Spain, discusses the goals of The EBMT Patient Advocacy Committee and shares the success of the Patient, Family, and Donor Day at EBMT 2024. The event included discussions on the future of cellular therapies and overcoming barriers to accessing them. Ms Bolaños emphasizes the importance of including quality of life (QoL) endpoints in clinical trials assessing cellular therapies and bone marrow transplantation (BMT). This interview took place at the 50th Annual Meeting of the EBMT in Glasgow, Scotland.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
